Cover Image

Subversion of drug testing programs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 17, 2005.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Format:	Government Document Book
Language:	English
Published:	Washington : U.S. G.P.O. : 2005.
Subjects:	Drug testing > Corrupt practices > United States.
Online Access:	PDF version:

Similar Items

Subversion of drug testing programs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 17, 2005.
Published: (2005)

Drug tests : products to defraud drug use screening tests are widely available : testimony before the Chairman, Subcommittee on Oversight and Investigations, Committeee on Energy and Commerce, House of Representatives /
by: Cramer, Robert J.
Published: (2005)

Ketek clinical study fraud : what did Aventis know? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008.
Published: (2008)

Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990.
Published: (1990)

Online pharmacies and the problem of Internet drug abuse : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Tenth Congress, second session, June 24, 2008.
Published: (2009)

Ketek clinical study fraud : what did Aventis know? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008.
Published: (2008)

Counterfeit drugs : fighting illegal supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 27, 2014.
Published: (2015)

An inquiry into the ImClone cancer-drug story : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002.
Published: (2002)

Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
Published: (2017)

The silicosis story : mass tort screening and the public health : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, second session, March 8, March 31, June 6, and July 26, 2006.
Published: (2006)

Sick crime : counterfeit drugs in the United States : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, November 1, 2005.
Published: (2006)

The financial collapse of Enron : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session.
Published: (2002)

Drugs in sports : compromising the health of athletes and undermining the integrity of competition : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, February 27, 2008.
Published: (2008)

The Volcker interim report on the United Nations Oil-for-Food Program : hearing before the Subcommittee on Oversight and Investigations of the Committee on International Relations, House of Representatives, One Hundred Ninth Congress, first session, February 9, 2005.
Published: (2005)

The United Nations Oil-for-Food Program : the Cotecna and Saybolt inspection firms : hearing before the Subcommittee on Oversight and Investigations of the Committee on International Relations, House of Representatives, One Hundred Ninth Congress, first session, March 17, 2005.
Published: (2005)

Magnitude, impact, and military response to Harrier jet and cruise missile testing improprieties by the Northrop Corporation : hearings before the Legislation and National Security Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred First Congress, second session, September 25; October 11 and 12, 1990.
Published: (1991)

Volkswagen's emissions cheating allegations : initial questions : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, October 8, 2015.
Published: (2016)

The SACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, June 8, 2021.
Published: (2021)

Parents be aware : health concerns about dietary supplements for overweight children : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, June 16, 2004.
Published: (2004)

Subcommittee report of "The Oil-For-Food Program, the Systematic [as printed] Failure of the United Nations" : markup before the Subcommittee on Oversight and Investigations of the Committee on International Relations, House of Representatives, One Hundred Ninth Congress, first session, December 7, 2005.
Published: (2006)

Deleting commercial pornography sites from the Internet : the U.S. financial industry's efforts to combat this problem : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, second session, September 21, 2006.
Published: (2006)

The flow of precursor chemicals and assault weapons from the United States into the Andean nations : hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives, One Hundred First Congress, first session, November 1, 1989.
Published: (1990)

Impact of potential restrictions on anti-drug media campaign contractors : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, second session, July 26, 2002.
Published: (2003)

Combating waste, fraud, and abuse in Medicaid's personal care services program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, May 2, 2017.
Published: (2017)

The U.S. Homeland Security role in the Mexican war against drug cartels : hearing before the Subcommittee on Oversight, Investigations, and Management of the Committee on Homeland Security, House of Representatives, One Hundred Twelfth Congress, first session, March 31, 2011.
Published: (2012)

Drug testing : undercover tests reveal significant vulnerabilities in DOT's drug testing program : testimony before the Subcommittee on Highways and Transit, Committee on Transportation and Infrastruture, House of Representatives /
by: Kutz, Gregory D.
Published: (2007)

"The ULLICO scandal and its implications for U.S. workers" : hearing before the Committee on Education and the Workforce, House of Representatives, One Hundred Eighth Congress, first session, hearing held in Washington, DC, June 17, 2003.
Published: (2003)

Assessing VA's risks for drug diversion : hearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Fifteenth Congress, first session, Monday, February 27, 2017.
Published: (2018)

Consumers shortchanged? : oversight of the Justice Department's mortgage lending settlements : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, first session, February 12, 2015.
Published: (2015)

The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)

The Enron collapse : joint hearing before the Subcommittee on Capital Markets, Insurance, and Government Sponsored Enterprises and the Subcommittee on Oversight and Investigations of the Committee on Financial Services, U.S. House of Representatives, One Hundred Seventh Congress.
Published: (2001)

Examining decades of data manipulation at the United States Geological Survey : oversight hearing before the Subcommittee on Oversight and Investigations of the Committee on Natural Resources, U.S. House of Representatives, One Hundred Fourteenth Congress, second session, Tuesday, December 6, 2016.
Published: (2017)

The IRS contracts with Strong Castle, Inc. : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Thirteenth Congress, first session, June 26, 2013.
Published: (2013)

Reviewing the rising price of EpiPens : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, September 21, 2016.
Published: (2017)

The role of Purdue Pharma and the Sackler family in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020.
Published: (2021)

Allegations of waste, fraud, and abuse in pharmaceutical pricing : financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007.
Published: (2007)

Examining patient access to investigational drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017.
Published: (2018)

Pharmaceutical supply chain security : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, July 11, 2006.
Published: (2007)

Predatory sales practices in Medicare Advantage : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 26, 2007.
Published: (2008)

FDA, Merck, and Vioxx : putting patient safety first? : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, November 18, 2004.
Published: (2005)